Results 71 to 80 of about 4,595,974 (209)

Which of the Direct Oral Anticoagulants Is the Safest?: Based on Gastrointestinal Bleeding

, 2017
Article: Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-based ...
Moo In Park, Kyoungwon Jung
core   +1 more source

Unprotected Left Main Disease: Clinical Outcomes Following Deferral, Coronary Artery Bypass Grafting, or Percutaneous Coronary Intervention

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background The prognostic benefit of revascularization for unprotected left main (LM) disease remains uncertain, as guideline endorsement of percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) precludes comparison with deferral, which is unlikely to be assessed in a randomized trial.
Marc Meller Bröchner, Evald Høj Christiansen, Kristian Kragholm, Lisette Okkels Jensen, Gennady Atroshchenko, Ivy Susanne Modrau, Lars Riber, Oliver Buchhave Pedersen, Leif Thuesen, Christian Torp‐Pedersen, Ashkan Eftekhari   +10 more
wiley   +1 more source

Percutaneous Left Atrial Appendage Closure Using a PFO Occluder After an Incomplete Surgical Ligation

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT The case regards a 73‐year‐old male who was referred for consideration of percutaneous left atrial appendage closure. His left atrial appendage was ligated during prior mitral valve surgery, but was noted to be patent on a recent transesophageal echocardiography. An Amulet device was selected based on CT planning.
Zach Rozenbaum, Eric Gnall
wiley   +1 more source

Perioperative Venous Thromboembolism (VTE) Prophylaxis in Thoracic Cancer Patients: Chinese Experts Consensus - Interpretation of Application Prospect of Direct Oral Anticoagulant

Chinese Journal of Lung Cancer, 2019
Venous thromboembolism (VTE) is a preventable perioperative complication of malignant tumor in thoracic surgery. At present, low molecular weight heparin anticoagulants are the first choices for perioperative drug prevention of malignant tumors, and ...
Ruiheng JIANG, Tong LI, Hui LI
doaj   +1 more source

Cangrelor Dosing, Administration, and Clinical Outcomes for Patients Undergoing Complex and High‐Risk Percutaneous Coronary Interventions

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Cangrelor reduces thrombotic events in patients undergoing percutaneous coronary intervention (PCI), with the advantage of rapid onset and offset. However, premature discontinuation may increase the risk of acute thrombosis for patients undergoing complex/high‐risk PCI (CHIP).
Siyu Ma, Wendy Y. Cheng, Yinong Liang, Josephine Bryar, Gwyneth Wei, Joshua D. Niznik, Christina Yin, Sue Liu‐Yi, Jimmy L. Kerrigan   +8 more
wiley   +1 more source

Direct oral anticoagulants: key considerations for use to prevent stroke in patients with nonvalvular atrial fibrillation

, 2015
Jerome Ment Department of Cardiology, Birmingham Heartlands Hospital, Birmingham, UK Abstract: Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide.
Ment J
core  

New oral anticoagulants in patients with nonvalvular atrial fibrillation: a review of pharmacokinetics, safety, efficacy, quality of life, and cost effectiveness

, 2014
Helen Mani, Edelgard Lindhoff-LastJohann Wolfgang Goethe-University Hospital Frankfurt/Main, Department of Internal Medicine, Division of Haemostasis, Frankfurt, GermanyAbstract: Atrial fibrillation (AF) continues to be a leading cause of cerebrovascular
Lindhoff-Last E, Mani, Helen, Mani H, Lindhoff-Last, Edelgard   +3 more
core   +1 more source

Effectiveness and safety of direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease: a systematic review and meta-analysis of clinical trials

Рациональная фармакотерапия в кардиологии
Aim. To analyze published clinical trials to evaluate the safety and effectiveness of direct oral anticoagulants in comparison with warfarin in a population of patients with atrial fibrillation and chronic kidney disease stages C4-C5.Material and methods.
E. M. Mezhonov, Z. M. Safiullina, Y. A. Vyalkina, S. V. Shalaev   +3 more
doaj   +1 more source

Guidance for Endoscopic Procedures in Patients Taking Novel Oral Anticoagulants

The Korean Journal of Helicobacter and Upper Gastrointestinal Research, 2016
Anticoagulant agents are used to reduce the risk of thromboembolic complications in patients with atrial fibrillation or deep vein thrombosis. Several new generation of oral anticoagulants have been approved.
Kyoung Oh Kim
doaj   +1 more source

One‐Year Clinical Outcomes of Paclitaxel‐Coated Balloon Angioplasty in Patients With and Without Acute Coronary Syndrome: The ALLIANCE Registry

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Real‐world data after percutaneous coronary intervention (PCI) using drug‐coated balloons (DCBs) in acute coronary syndrome (ACS) are limited. Aims We compared 1‐year clinical outcomes after PCI with paclitaxel DCBs between the ACS and non‐ACS patients.
Takashi Muramatsu, Kengo Tanabe, Kazushige Kadota, Yutaka Tadano, Kenji Ando, Shigeru Nakamura, Takashi Ashikaga, Yoshihisa Kinoshita, Nehiro Kuriyama, Yuko Ohnishi, Toru Kataoka, Koji Nishida, Raisuke Iijima, Masatsugu Nozoe, Kunio Morishige, Takefumi Takahashi, Yoshitaka Murakami, Ken Kozuma, Masato Nakamura   +18 more
wiley   +1 more source